SentienBiotech

134 posts

SentienBiotech banner
SentienBiotech

SentienBiotech

@SentienBiotech

Sentien Biotechnologies, Inc. is a privately owned, clinical-stage company developing novel approaches to cell therapy.

参加日 Nisan 2017
232 フォロー中224 フォロワー
SentienBiotech がリツイート
Blaithin A. McMahon
Blaithin A. McMahon@McmahonBlaithin·
SB-101 running in series w HF1400 filter to allow sustained 24hr delivery of regenerative products from human mesenchymal stems cells (SB-101) in a COVID19 AKI pt on CRRT. A milestone for the field of stem cell research. @musc_nephrology @MUSChealth @SentienBiotech @crrtonline
Blaithin A. McMahon tweet mediaBlaithin A. McMahon tweet media
English
0
1
17
0
SentienBiotech がリツイート
Johannes Fruehauf🇺🇦
Johannes Fruehauf🇺🇦@JFruehauf·
Congratulations @sentienbiotech team for this publication and important progress with your work. Restoring balance to the immune system through extra-corporeal treatment with stem cells. Science fiction? It’s already here!
SentienBiotech@SentienBiotech

Read @SentienBiotech's new publication with data from our first Ph I/II study of SBI-101 in subjects with AKI! Data supports the therapeutic hypothesis that ex vivo delivery of MSC-secreted factors leads to immunomodulation & reprogramming of immune cells …cellsjournals.onlinelibrary.wiley.com/doi/full/10.10…

English
0
1
2
0
SentienBiotech
SentienBiotech@SentienBiotech·
@SentienBiotech has received an award from @MD_Stem_Cell to help fund Sentien's clinical study of SBI-101 for the treatment of acute kidney injury associated with sepsis (including from #COVID19)! #celltherapy #MSC
MSCRF@MD_Stem_Cell

.@MD_Stem_Cell Research Commission Announces $1M in 3 New Awards to Accelerate Cures For: • Primary Immunodeficiencies/Inherited Bone Marrow Failures • Craniofacial/Bone Defects • Sepsis/Acute Kidney Injury Read Press Release: bit.ly/3tUAT5a #biotech #health

English
0
0
2
0
SentienBiotech
SentienBiotech@SentienBiotech·
Register for this webinar on Wed 4/28 with @SentienBiotech VP of R&D, Dr. Rita Barcia, discussing considerations for #MSC product and process development through clinical cGMP manufacturing, alongside other distinguished panelists! @RoosterBio @jan_nolta
Cell & Gene Therapy@CGT_Insights

Don't miss next week's webinar on key considerations for hMSC product and process development through clinical cGMP manufacturing (April 28th, 11am ET); bit.ly/3eiheoC @CGT_Insights #CellTherapy

English
0
3
5
0
SentienBiotech
SentienBiotech@SentienBiotech·
@SentienBiotech's new publication highlights the ability of our ex-vivo cell therapy approach to reduce clotting in vitro, an important advantage relative to IV delivery. Particularly relevant in treating #COVID19 patients who tend to be hypercoagulable. biorxiv.org/content/10.110…
English
0
0
3
0
SentienBiotech
SentienBiotech@SentienBiotech·
@SentienBiotech SVP of Operations @ChrisGemmiti to speak on a panel tomorrow at the Cell & Gene Therapy Bioprocessing & Commercialization virtual meeting on Strategies and Challenges in Manufacturing and Commercialization! #CGTCONF #celltherapy #MSC #cell-therapy_panel-strategies-and-challenges-in-manufacturing-and-commercialization" target="_blank" rel="nofollow noopener">informaconnect.com/cell-therapy-b…
SentienBiotech tweet media
English
0
1
2
0

ディスカバー

@musc_nephrology @MUSChealth @crrtonline @alliancerm @StemCellsTM @MD_Stem_Cell @BARDA @WorldSepsisDay